US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ProShares Ultra Nasdaq Biotechnology

116.60

+0.20700.18%

Post-market: 116.600.0032+0.00%19:30 EDT

Volume:10K

Turnover:1.13M

Market Cap:101.44M

PE:- -

High:116.74

Open:116.27

Low:113.31

Close:116.39

52wk High:126.40

52wk Low:55.34

Shares:870.00K

Float Shares:870.00K

Volume Ratio:0.88

T/O Rate:1.13%

Dividend:0.33

Dividend Rate:0.28%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus

Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential

Political and General News Events from August 24

EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC

Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc

THOMSON REUTERS

European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status

THOMSON REUTERS

Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027

Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?

Simply Wall St.

Funds: What a Top Biotech Fund is Buying Now

Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60

Moderna Inc. Stock Advances 8.9%, Outperforms Peers

Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit

Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study

Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block

Simply Wall St.

Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors

Moderna Inc. Stock Slips 23.5%, Underperforms Peers

Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial

Wall Street Analysts Are Bullish on Top Healthcare Picks

Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors

Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://sg.tigeractivity.com/stock/BIB/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BIB","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","market":"US","secType":"STK","nameCN":"ProShares Ultra Nasdaq Biotechnology","latestPrice":116.5968,"timestamp":1788206400000,"preClose":116.3898,"halted":0,"volume":9835,"hourTrading":{"tag":"盘后","latestPrice":116.6,"preClose":116.5968,"latestTime":"19:30 EDT","volume":13,"amount":1515.464,"timestamp":1788219002070,"change":0.0032,"changeRate":0.000027,"amplitude":0},"delay":0,"changeRate":0.001778506363959796,"floatShares":870000,"shares":870000,"eps":0,"marketStatus":"Closed","change":0.207,"latestTime":"08-31 16:00:00 EDT","open":116.27,"high":116.74,"low":113.31,"amount":1133602.00604,"amplitude":0.02947,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1788249600000},"marketStatusCode":5,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":116.3898,"sharesOutstanding":1040000,"nav":116.3208,"aum":101199096,"dividendRate":0.002795,"bidAskSpread":0.003041,"preHourTrading":{"tag":"盘前","latestPrice":115,"preClose":116.3898,"latestTime":"09:28 EDT","volume":3,"amount":345,"timestamp":1788182910008,"change":-1.3898,"changeRate":-0.011941,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":116.6,"preClose":116.5968,"latestTime":"19:30 EDT","volume":13,"amount":1515.464,"timestamp":1788219002070,"change":0.0032,"changeRate":0.000027,"amplitude":0},"volumeRatio":0.883188,"impliedVol":0.4833,"impliedVolPercentile":0.757},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BIB\",,,,,undefined,":{"symbol":"BIB","floatShares":870000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.883188,"shares":870000,"dividePrice":0.3259,"high":116.74,"amplitude":0.02947,"preClose":116.3898,"low":113.31,"week52Low":55.34,"pbRate":"--","week52High":126.399,"institutionHeld":0,"latestPrice":116.5968,"eps":0,"divideRate":0.002795,"volume":9835,"delay":0,"ttmEps":0,"open":116.27,"prevYearClose":79.7794,"prevWeekClose":116.3898,"prevMonthClose":96.6087,"prevQuarterClose":100.74,"fiveDayClose":120.906,"twentyDayClose":96.08,"sixtyDayClose":83.0787},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BIB\",params:#limit:5,,,undefined,":[{"date":"2026-03-25","symbol":"BIB","amount":0.00714,"announcedDate":"2026-03-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-25","defaultRemindTime":1774445400000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-25","currency":"USD","dateTimestamp":1774411200000,"payDate":"2026-03-31"},{"date":"2025-12-24","symbol":"BIB","amount":0.134637,"announcedDate":"2025-12-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-24","defaultRemindTime":1766586600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-24","currency":"USD","dateTimestamp":1766552400000,"payDate":"2025-12-31"},{"date":"2025-09-24","symbol":"BIB","amount":0.180541,"announcedDate":"2025-09-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-24","defaultRemindTime":1758720600000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-30","payableDate":"2025-09-24","currency":"USD","dateTimestamp":1758686400000,"payDate":"2025-09-30"},{"date":"2025-06-25","symbol":"BIB","amount":0.170576,"announcedDate":"2025-06-24","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-06-25","defaultRemindTime":1750858200000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-07-01","payableDate":"2025-06-25","currency":"USD","dateTimestamp":1750824000000,"payDate":"2025-07-01"},{"date":"2025-03-26","symbol":"BIB","amount":0.130939,"announcedDate":"2025-03-25","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-03-26","defaultRemindTime":1742995800000,"name":"Ultra纳斯达克生物科","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-04-01","payableDate":"2025-03-26","currency":"USD","dateTimestamp":1742961600000,"payDate":"2025-04-01"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BIB\",market:\"US\",,,undefined,":[{"executeDate":"2022-12-22","recordDate":"2022-12-23","paymentDate":"2022-12-30","value":0.019852,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-28","value":0.038393,"currency":"USD"},{"executeDate":"2024-03-20","recordDate":"2024-03-21","paymentDate":"2024-03-27","value":0.040324,"currency":"USD"},{"executeDate":"2024-06-26","recordDate":"2024-06-26","paymentDate":"2024-07-03","value":0.26476,"currency":"USD"},{"executeDate":"2024-09-25","recordDate":"2024-09-25","paymentDate":"2024-10-02","value":0.15285,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BIB\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BIB\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662205709","title":"Lakefront Biotherapeutics Wins FDA Orphan Drug Status for Gamgertamig in Pemphigus","url":"https://stock-news.laohu8.com/highlight/detail?id=2662205709","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662205709?lang=en_us&edition=fundamental","pubTime":"2026-08-25 04:01","pubTimestamp":1787601693,"startTime":"0","endTime":"0","summary":"Lakefront Biotherapeutics wins FDA orphan drug status for gamgertamig in pemphigusFDA granted orphan drug designation to gamgertamig for pemphigus.The drug already holds FDA fast track and orphan stat","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL5cnKbj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","BIB","LU0965508806.USD","LU2089984988.USD","LU0320765992.SGD","LU1023059063.AUD","TBXU","IBB","IE00B64PRP62.GBP","IE00BN0W2W23.USD","BK4566","LU1037948541.HKD","LU0234570918.USD","LU1066051498.USD","IE00BKVL7J92.USD","IE00BQXX3C00.GBP","NDAQ","LU2095319765.USD","BK4568","GILD","IE00BQXX3F31.USD","LU0122379950.USD","IE00BN0W2V16.EUR","LU0965509010.AUD","IBBQ","LU2324357040.USD","SG9999014013.SGD","LU2210149790.SGD","IE00BN0W2T93.GBP","IE00BKPKM429.USD","LU1430594728.SGD","LU2087621335.USD","SG9999015978.USD","BK4578","BMED","BBH","MEDI","IE0002270589.USD","LU2210150020.SGD","LU0861579265.USD","LU0289739699.SGD","IE00BZ1G4Q59.USD","SG9999015952.SGD","SG9999014039.USD","TMED","BK4139","LU1674673691.USD","IE00B19Z3B42.SGD","LU0859254822.USD","BK4550"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662729270","title":"Amgen Extends MariTide Study In Obesity And Diabetes, Keeping Investor Focus On Long-Term Potential","url":"https://stock-news.laohu8.com/highlight/detail?id=2662729270","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662729270?lang=en_us&edition=fundamental","pubTime":"2026-08-25 00:31","pubTimestamp":1787589063,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen Inc. is moving ahead with MARITIME-2-EXTENSION, a Phase 3 trial that t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-extends-maritide-study-in-obesity-and-diabetes-keeping-investor-focus-on-long-term-potential?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-extends-maritide-study-in-obesity-and-diabetes-keeping-investor-focus-on-long-term-potential?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU1023059063.AUD","BBC","BIB","BK4581","IE00BJJMRZ35.SGD","LU0109394709.USD","SG9999001440.SGD","PBE","BK4585","IBBQ","BK4588","IE00BJT1NW94.SGD","LU0320765992.SGD","IE0002141913.USD","LU2112291526.USD","LU1983299246.USD","LU1057294990.SGD","LU2242646821.SGD","LU0889565916.HKD","PSIL","BK4566","LU0289739699.SGD","LU2089984988.USD","IE0009355771.USD","LU0058720904.USD","LU0868494617.USD","BK4139","BK4534","LU1571399168.USD","LU2468319806.SGD","IE00BFTCPJ56.SGD","IE00B2B36J28.USD","BBH","IE00B4R5TH58.HKD","IBB","LU0122379950.USD","TBXU","LU2242652126.USD","LU1061106388.HKD","AMGN","PJP","BK4599"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661271512","title":"Political and General News Events from August 24","url":"https://stock-news.laohu8.com/highlight/detail?id=2661271512","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661271512?lang=en_us&edition=fundamental","pubTime":"2026-08-24 21:19","pubTimestamp":1787577552,"startTime":"0","endTime":"0","summary":"DIARY-Political and General News Events from August 24Aug 24 (Reuters)-For other diaries, please see:Political andGeneral NewsPOL/DIARYTop Economic EventsM/DIARYEmerging Markets Economic EventsEMRG/DI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4N44L0XV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","BK4599","LU0289739699.SGD","IE00BJT1NW94.SGD","IE0009355771.USD","LU2468319806.SGD","BK4566","AMGN","LU0320765992.SGD","LU0109394709.USD","LU2242646821.SGD","BK4581","IBB","BK4585","TBXU","IE00BJJMRZ35.SGD","BK4139","SG9999001440.SGD","LU1061106388.HKD","BK4588","LU0058720904.USD","LU0868494617.USD","LU2112291526.USD","PBE","LU2242652126.USD","PJP","LU1571399168.USD","IE0002141913.USD","BK4533","BBH","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1983299246.USD","LU2089984988.USD","LU0889565916.HKD","BIB","IE00B4R5TH58.HKD","IBBQ","LU1057294990.SGD","LU0122379950.USD","BK4534"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278374","title":"EU Commission Approves Gilead Trodelvy-Keytruda Combo for First-Line PD-L1+ Metastatic TNBC","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278374","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278374?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567503,"startTime":"0","endTime":"0","summary":"EU Commission approves Gilead Trodelvy-Keytruda combo for first-line PD-L1+ metastatic TNBCEuropean Commission granted marketing authorization for Trodelvy with Merck’s Keytruda in first-line metastat","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDL4gZS8y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","GILD","LU1023059063.AUD","LU0965509101.SGD","IBBQ","LU1571399168.USD","IE00B3T34201.USD","BBH","LU1037948541.HKD","TBXU","SG9999015978.USD","BIB","LU1066051498.USD","LU1585245621.USD","MEDI","LU0861579265.USD","LU1674673691.USD","SG9999015952.SGD","LU0882574055.USD","BK4566","LU2357627491.SGD","BK4583","IBB","LU0058720904.USD","LU0965509010.AUD","LU0823416689.USD","LU0289739699.SGD","BK4550","IE0002270589.USD","LU2468319806.SGD","LU1037948897.HKD","LU0965509283.SGD","LU1934455277.USD","LU0114720955.EUR","LU0859254822.USD","LU0965508806.USD","SG9999015986.USD","IE00BZ1G4Q59.USD","LU1057294990.SGD","LU0109394709.USD","LU0320765992.SGD","LU1061106388.HKD","LU1430594728.SGD","LU1778281490.HKD","LU1934455863.HKD","IE00B19Z3581.USD","LU2089984988.USD","BMED","BK4585","TMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661325278","title":"Gilead - EU Grants Marketing Authorization for Trodelvy with Keytruda in First-Line Pd-L1-Positive Metastatic Tnbc","url":"https://stock-news.laohu8.com/highlight/detail?id=2661325278","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661325278?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["SG9999015978.USD","LU2324357040.USD","BK4588","SG9999015952.SGD","LU1839511570.USD","BMED","IBBQ","BBH","IE0002270589.USD","LU2357627491.SGD","IE00B7SZLL34.SGD","LU0965509010.AUD","LU0234570918.USD","GILD","SG9999015986.USD","SG9999015945.SGD","IE00B19Z3B42.SGD","IE00BSNM7G36.USD","LU0965509283.SGD","LU0058720904.USD","LU0889565916.HKD","LU0289739699.SGD","LU0965508806.USD","TBXU","BK4550","LU1061106388.HKD","BK4139","LU1934455863.HKD","IE00B3T34201.USD","LU1674673691.USD","IBB","LU2468319806.SGD","MEDI","LU1066051498.USD","LU1057294990.SGD","BIB","LU1934455277.USD","BK4566","IE00BZ1G4Q59.USD","LU0320765992.SGD","LU1037948897.HKD","LU1674673428.USD","LU0965509101.SGD","LU1066053197.SGD","LU1934455194.USD","TMED","LU1585245621.USD","BK4585","LU1023059063.AUD","BK4568"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661278323","title":"European Commission Expands Role of Gilead’s Trodelvy® in First-Line Metastatic Triple-Negative Breast Cancer Across Pd-L1 Status","url":"https://stock-news.laohu8.com/highlight/detail?id=2661278323","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661278323?lang=en_us&edition=fundamental","pubTime":"2026-08-24 18:31","pubTimestamp":1787567460,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nTUAMP4X3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","LU0058720904.USD","BK4585","LU1585245621.USD","LU2089984988.USD","SG9999015978.USD","MEDI","BBH","IE00B19Z3B42.SGD","LU0320765992.SGD","IE00B7SZLL34.SGD","BIB","LU2087621335.USD","LU0109394709.USD","LU0965509101.SGD","SG9999015952.SGD","LU0234570918.USD","BK4532","LU0122379950.USD","LU0823416689.USD","BK4139","LU0861579265.USD","LU1674673691.USD","SG9999015945.SGD","TBXU","LU0859254822.USD","IBBQ","BK4583","LU1066053197.SGD","BMED","LU0289739699.SGD","IE00B19Z3581.USD","BK4566","SG9999015986.USD","TMED","LU2324357040.USD","LU0882574055.USD","GILD","LU2357627491.SGD","LU1057294990.SGD","IBB","LU1674673428.USD","LU0114720955.EUR","LU1061106388.HKD","LU1037948541.HKD","LU1037948897.HKD","IE00BKVL7J92.USD","BK4588","LU0889565916.HKD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661222504","title":"Daiichi Sankyo Names Ken Keller Chief Commercialization Officer, Effective April 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2661222504","media":"Reuters","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661222504?lang=en_us&edition=fundamental","pubTime":"2026-08-24 15:00","pubTimestamp":1787554851,"startTime":"0","endTime":"0","summary":"Daiichi Sankyo names Ken Keller chief commercialization officer, effective April 2027Daiichi Sankyo named Ken Keller chief commercialization officer, effective April 1, 2027, to run a new globally int","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nNDLbyMxfX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B4R5TH58.HKD","BK4533","LU1983299246.USD","LU1057294990.SGD","BK4585","LU1571399168.USD","LU2112291526.USD","BK4534","LU0109394709.USD","BIB","SG9999001440.SGD","LU0289739699.SGD","IBBQ","BK4566","LU0320765992.SGD","TBXU","BBH","LU2242646821.SGD","IE00BJT1NW94.SGD","LU2089984988.USD","IE00B2B36J28.USD","LU1061106388.HKD","IE00BJJMRZ35.SGD","IE0009355771.USD","BK4581","IE00BFTCPJ56.SGD","PJP","AMGN","BK4599","LU0058720904.USD","BK4588","LU0889565916.HKD","IE0002141913.USD","LU1023059063.AUD","PBE","BK4139","LU0122379950.USD","LU2242652126.USD","LU2468319806.SGD","LU0868494617.USD","IBB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661228075","title":"Is Viavi Solutions (VIAV) Quietly Recasting Its 6G Moat With the Vertex 6.0 Launch?","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228075","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228075?lang=en_us&edition=fundamental","pubTime":"2026-08-24 11:29","pubTimestamp":1787542174,"startTime":"0","endTime":"0","summary":"Earlier in August 2026, VIAVI Solutions launched Vertex 6.0, an enhanced channel emulation platform with 400 MHz instantaneous bandwidth and support for carrier frequencies up to 23.6 GHz, targeting next-generation 6G and Wi‑Fi 7/8 testing and integrating real-world RF propagation into lab environments.\nThis upgrade, the first since acquiring Spirent’s high-speed Ethernet, network security and channel emulation testing business, positions Vertex 6.0 as a modular RF digital twin platform...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/8111000-choice1-main-header/1585186745276"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/tech/nasdaq-viav/viavi-solutions/news/is-viavi-solutions-viav-quietly-recasting-its-6g-moat-with-t","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["IBBQ","IE0002141913.USD","LU2236285917.USD","SG9999013999.USD","LU0240877869.USD","LU2065171311.SGD","AGIX","LU0432979614.USD","IE00B19Z9Z06.USD","LU2065170008.USD","LU1585245621.USD","BK4532","AIPO","IDNA","SG9999001176.SGD","LU2065171402.SGD","BK4588","LU1069344957.HKD","QTOC","LU2089984988.USD","LU1559883803.SGD","PBE","VERX","BBH","LU0109394709.USD","VTHR","VIAG","LU1093756325.SGD","LU2417539215.USD","LU2462157665.USD","LU0889565916.HKD","VIAV","VRTX","BK4567","CHAT","GNMX","IE00B4R5TH58.HKD","BK4023","LU1674673428.USD","BIB","TBXU","LU0061475181.USD","ARTY","LU0234570918.USD","IBB","BK4585","LU2362540622.SGD","LU0205194284.USD","LU0417517546.SGD","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661213210","title":"Funds: What a Top Biotech Fund is Buying Now","url":"https://stock-news.laohu8.com/highlight/detail?id=2661213210","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661213210?lang=en_us&edition=fundamental","pubTime":"2026-08-22 09:30","pubTimestamp":1787362200,"startTime":"0","endTime":"0","summary":"It's hard to find a more experienced biotech investor than Evan McCulloch. The manager of Franklin Biotechnology Discovery has been running the $1.2 billion fund since 1997.That matters in this highly","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","GILD","PBE","LU2324357040.USD","LU2112291526.USD","IE00B894F039.SGD","LU1674673691.USD","BK4567","LU0889565916.HKD","LU0061475181.USD","IBBQ","IE00B3T34201.USD","SGXZ57979304.SGD","LU1430594728.SGD","VRTX","IE00B19Z3581.USD","LU0154245673.USD","LU1037948897.HKD","LU2237438978.USD","LU2362541273.HKD","LU1934455863.HKD","LU0965509283.SGD","BK4566","IE00BJJMRZ35.SGD","LU0823434740.USD","LU0154245756.USD","LU1778281490.HKD","LU1066053197.SGD","LU0234570918.USD","LU1674673428.USD","IBB","LU0053666078.USD","LU1069344957.HKD","JAZZ","TMED","SG9999013999.USD","LU2362541513.USD","AMGN","LU2087621335.USD","PJP","LU1839511570.USD","IE00BZ9MQY76.HKD","LU1974910355.USD","BK4583","LU2417539215.USD","BIB","SG9999015986.USD","LU0859254822.USD","BK4568","LU0114720955.EUR","LU0823416689.USD","BMED","BK4599","IE0002270589.USD","LU2462157665.USD","LU2362540622.SGD","LU0823434583.USD","BK4532","LU0882574055.USD","IE00BJT1NW94.SGD","LU0109394709.USD","LU1093756168.USD","LU2106854487.HKD","SG9999001176.SGD","04332","IE00BN0W2V16.EUR","REGN","LU1066051498.USD","LU0861579265.USD","TBXU","BK4585","LU2242652126.USD","IE00B19Z9Z06.USD","LU1057294990.SGD","LU2023250504.SGD","MEDI","LU1037948541.HKD","BK4007","IE00BKVL7J92.USD","LU2242646821.SGD","IE00BSNM7G36.USD","LU1585245621.USD","LU1035775433.USD","IE00BZ1G4Q59.USD","LU0256863811.USD","BK4578","IE00B19Z9P08.USD","BK4533","LU1571399168.USD","LU0868494617.USD","BK4550","LU0122379950.USD","LU0417517546.SGD","LU2456880835.USD","LU1023059063.AUD","LU0058720904.USD","LU0079474960.USD","SG9999015945.SGD","LU0320765992.SGD","LU1934455194.USD","BK4139","IE0002141913.USD","IE00B4R5TH58.HKD","LU0965509010.AUD","SG9999001176.USD","IE00B7SZLL34.SGD","LU1093756325.SGD","BBH","SG9999015952.SGD","LU2236285917.USD","LU0432979614.USD","IE00B19Z3B42.SGD","XBI","IE00BN0W2W23.USD","LU0965509101.SGD","LU0965508806.USD","IDNA","BK4581","IE0009355771.USD","IE00BFTCPJ56.SGD","LU1983299246.USD","SG9999015978.USD","LU2357627491.SGD","IE00BN0W2T93.GBP","IE00B2B36J28.USD","LU1934455277.USD","BK4588","LU1917777945.USD","LU2468319806.SGD","LU2089984988.USD","GNMX","LU0289739699.SGD","SG9999001440.SGD","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661187372","title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","url":"https://stock-news.laohu8.com/highlight/detail?id=2661187372","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661187372?lang=en_us&edition=fundamental","pubTime":"2026-08-22 07:22","pubTimestamp":1787354576,"startTime":"0","endTime":"0","summary":"Gilead director Jeffrey Bluestone disposes of 5,000 common shares worth $727,333.60Gilead director Jeffrey Bluestone exercised stock options on Aug. 20, 2026, acquiring 5,000 shares at USD 61.35 to US","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL4cgVd7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Gilead Director Jeffrey Bluestone Disposes of 5,000 Common Shares Worth $727,333.60","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBB","IE00BSNM7G36.USD","LU0234570918.USD","BIB","LU0882574055.USD","LU1430594728.SGD","LU1674673428.USD","LU0289739699.SGD","SG9999015978.USD","LU1066053197.SGD","LU0965509283.SGD","LU0965509010.AUD","LU1023059063.AUD","IE00B19Z3B42.SGD","LU0058720904.USD","BBH","TMED","MEDI","LU2468319806.SGD","LU0965509101.SGD","LU1934455863.HKD","IE00B7SZLL34.SGD","LU1674673691.USD","SG9999015952.SGD","LU2087621335.USD","BK4566","LU1778281490.HKD","BK4532","IE00B19Z3581.USD","LU1057294990.SGD","BMED","LU0861579265.USD","LU1585245621.USD","SG9999015945.SGD","LU0122379950.USD","LU1571399168.USD","GILD","SG9999015986.USD","BK4588","IBBQ","LU2089984988.USD","BK4568","LU0320765992.SGD","LU0859254822.USD","BK4139","LU2357627491.SGD","BK4583","TBXU","LU0965508806.USD","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661972042","title":"Moderna Inc. Stock Advances 8.9%, Outperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661972042","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661972042?lang=en_us&edition=fundamental","pubTime":"2026-08-22 04:33","pubTimestamp":1787344380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. rose 8.9% to $145.13 on what proved to be an all-around favorable trading session for the stock market, with the NASDAQ Composite Index rising 0.4% to 26,180.45 and the Dow Jones Industrial Average rising 1.0% to 53,277.01.Moderna Inc. closed 17.8% below its 52-week high of $176.66, which the company reached on August 19th.The stock outperformed some of its peers, as Johnson & Johnson rose 1.1% to $270.24, Pfizer Inc. rose 1.0% to $28.07, and Gilead Sciences Inc. rose 1.87% to $146.12.Trading volume totaled 86.7 million, compared to the 50-day average of 13.0 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1934455194.USD","BK4532","LU1037948541.HKD","BK4583","LU1430594728.SGD","LU1585245621.USD","BIB","LU0861579265.USD","IBB","TMED","LU1674673691.USD","LU0965509283.SGD","LU0823416689.USD","LU1061106388.HKD","MRNX","SG9999015986.USD","LU2324357040.USD","BMED","LU0320765992.SGD","WDNA","IBBQ","MRNY","BK4585","LU1066053197.SGD","SG9999015952.SGD","GNOM","LU0289739699.SGD","LU0965509010.AUD","BK4501","IE0002270589.USD","LU1934455863.HKD","LU0965508806.USD","BK4550","IDNA","LU1057294990.SGD","BK4551","LU0122379950.USD","LU1839511570.USD","LU0058720904.USD","BBH","LU1571399168.USD","GILD","LU0234570918.USD","MEDI","LGHT","MRNA","SG9999015978.USD","LU2357627491.SGD","TBXU","LU2112291526.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661940352","title":"Gilead Declares Q3 2026 Dividend of R$ 0.24 Per Unit","url":"https://stock-news.laohu8.com/highlight/detail?id=2661940352","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661940352?lang=en_us&edition=fundamental","pubTime":"2026-08-22 01:58","pubTimestamp":1787335117,"startTime":"0","endTime":"0","summary":"Gilead declares Q3 2026 dividend of R$ 0.24 per unitGilead Sciences set a Q3 2026 distribution of R$ 0.24 per unit for BRGILDBDR 000.Last day to trade with rights: Sept. 11, 2026.Payment date: Oct. 5,","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nNDL12Yy9R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDI","TBXU","LU0889565916.HKD","BBH","GILD","BK4532","LU0965509283.SGD","IE00BSNM7G36.USD","IBBQ","IE00B19Z3B42.SGD","LU1061106388.HKD","LU0122379950.USD","LU0320765992.SGD","BK4568","IE00B3T34201.USD","LU1430594728.SGD","IE00BKVL7J92.USD","LU0965509101.SGD","BK4578","LU0882574055.USD","IBB","LU1066053197.SGD","LU0823416689.USD","LU1674673428.USD","LU2357627491.SGD","BK4585","LU2112291526.USD","LU0114720955.EUR","LU1037948541.HKD","BK4139","SG9999015986.USD","BK4583","LU0859254822.USD","IE00B7SZLL34.SGD","LU2324357040.USD","LU2089984988.USD","BK4550","BIB","LU1585245621.USD","LU0965508806.USD","LU2468319806.SGD","BK4588","BMED","LU1037948897.HKD","IE0002270589.USD","LU0965509010.AUD","SG9999015952.SGD","LU1674673691.USD","TMED","LU1023059063.AUD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661887294","title":"Amgen Advances Tarlatamab Shot vs. Infusion in Phase 3 Lung Cancer Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2661887294","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661887294?lang=en_us&edition=fundamental","pubTime":"2026-08-22 00:34","pubTimestamp":1787330049,"startTime":"0","endTime":"0","summary":"Amgen Inc ($AMGN) announced an update on their ongoing clinical study. Amgen’s new Phase 3 DeLLphi-315 study tests its cancer drug tarlatamab in pe...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/amgen-advances-tarlatamab-shot-vs-infusion-in-phase-3-lung-cancer-study?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU2242646821.SGD","LU0058720904.USD","AMGN","LU0889565916.HKD","BIB","LU2242652126.USD","BK4588","PJP","LU1023059063.AUD","LU2112291526.USD","LU0868494617.USD","LU0289739699.SGD","BK4599","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","IBB","LU0320765992.SGD","PBE","BBH","IBBQ","IE00B2B36J28.USD","LU1983299246.USD","LU2089984988.USD","TBXU","BK4533","SG9999001440.SGD","BK4566","BK4139","IE0002141913.USD","BK4581","BK4534","BK4585","LU1571399168.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661923014","title":"Gilead (GILD) Stock Still Looks Below Fair Value As Court Backs HIV Import Block","url":"https://stock-news.laohu8.com/highlight/detail?id=2661923014","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661923014?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258134,"startTime":"0","endTime":"0","summary":"Gilead Sciences stock has delivered very strong long term returns over the past five years, yet current valuation checks and market multiples still point to the shares screening as undervalued. With recent news flow focused on its HIV and oncology franchises and on legal protection of its U.S. drug pricing, investors are weighing how much of this is already reflected in the price.\n\nGilead Sciences has returned 148.1% over the past five years, which puts recent valuation questions in the...","market":"sg","thumbnail":"https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/company-cover/29002-main-header/1756252861953"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-gild/gilead-sciences/news/gilead-gild-stock-still-looks-below-fair-value-as-court-back","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BMED","TBXU","LU1037948541.HKD","BBH","LU0109394709.USD","LU0889565916.HKD","LU1778281490.HKD","TSPA","LU1037948897.HKD","IE00B19Z3B42.SGD","IBB","SG9999015986.USD","LU0114720955.EUR","IE00BKVL7J92.USD","LU1430594728.SGD","BK4550","IE00BSNM7G36.USD","IBBQ","BIB","BK4588","IE0002270589.USD","LU0320765992.SGD","LU2087621335.USD","TMED","LU1934455194.USD","LU0965509283.SGD","LU2468319806.SGD","LU0823416689.USD","MEDI","LU0289739699.SGD","LU1934455863.HKD","LU0122379950.USD","DAPP","CDIG","BK4585","LU0965509010.AUD","TACU","LU1934455277.USD","GILD","LU2112291526.USD","BK4566","LU0861579265.USD","IE00BZ1G4Q59.USD","LU0965508806.USD","SG9999015978.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU1066051498.USD","SG9999015945.SGD","LU2089984988.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232279","title":"Gilead Sciences Inc. Stock Underperforms Thursday When Compared to Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232279","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232279?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:35","pubTimestamp":1787258100,"startTime":"0","endTime":"0","summary":"DJ Gilead Sciences Inc. Stock Underperforms Thursday When Compared To CompetitorsThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Gilead Sciences Inc.  slipped 2.82% to $143.44 Thursday, on what proved to be an all-around dismal trading session for the stock market, with the S&P 500 Index  falling 0.87% to 7,641.16 and Dow Jones Industrial Average  falling 1.32% to 52,759.21.The stock's fall snapped a seven-day winning streak.Gilead Sciences Inc. closed 8.81% below its 52-week high of $157.29, which the company achieved on February 11th.The stock underperformed when compared to some of its competitors Thursday, as Johnson & Johnson  fell 2.21% to $267.37, Pfizer Inc.  fell 1.59% to $27.79, and Abbott Laboratories  fell 0.25% to $114.14.Trading volume  remained 286,153 below its 50-day average volume of 7.4 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 20, 2026.","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4532","BMED","LU1585245621.USD","BK4578","LU0965509101.SGD","TBXU","LU1037948541.HKD","BBH","LU0109394709.USD","LU0889565916.HKD","LU1778281490.HKD","SG9999015952.SGD","LU1061106388.HKD","BK4568","LU1066053197.SGD","LU1037948897.HKD","IE00B19Z3B42.SGD","IBB","SG9999015986.USD","LU0114720955.EUR","IE00BKVL7J92.USD","LU1430594728.SGD","LU1839511570.USD","BK4550","IE00BSNM7G36.USD","IBBQ","BIB","BK4583","BK4588","IE0002270589.USD","LU0320765992.SGD","LU2087621335.USD","TMED","LU1934455194.USD","LU0965509283.SGD","LU2468319806.SGD","LU0234570918.USD","LU0823416689.USD","LU0289739699.SGD","MEDI","LU1934455863.HKD","LU0122379950.USD","IE00B3T34201.USD","BK4585","IE00B7SZLL34.SGD","LU1674673691.USD","LU2089984988.USD","LU0965509010.AUD","LU1674673428.USD","LU0058720904.USD","LU1934455277.USD","BK4139","GILD","LU2112291526.USD","BK4566","LU0861579265.USD","IE00BZ1G4Q59.USD","LU1023059063.AUD","LU0965508806.USD","SG9999015978.USD","LU1057294990.SGD","IE00B19Z3581.USD","LU1066051498.USD","LU1571399168.USD","SG9999015945.SGD","LU0882574055.USD","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661232427","title":"Moderna Inc. Stock Slips 23.5%, Underperforms Peers","url":"https://stock-news.laohu8.com/highlight/detail?id=2661232427","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661232427?lang=en_us&edition=fundamental","pubTime":"2026-08-21 04:33","pubTimestamp":1787257980,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Moderna Inc. cratered 23.5% to $133.32 on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index falling 1.0% to 26,067.17 and Dow Jones Industrial Average falling 1.3% to 52,759.21.Moderna Inc. closed 24.5% short of its 52-week high of $176.66, which the company reached on August 19th.The stock underperformed when compared to some of its peers, as Johnson & Johnson fell 2.2% to $267.37, Pfizer Inc. fell 1.6% to $27.79, and Gilead Sciences Inc. fell 2.82% to $143.44.Trading volume totaled 97.3 million, compared to the 50-day average of 11.2 million.Data source: Dow Jones Market Data, FactSet","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MRNA","GILD","LU1934455194.USD","BK4139","LU2324357040.USD","LU2112291526.USD","LU0965509010.AUD","TBXU","IE00B7SZLL34.SGD","LU1839511570.USD","WDNA","LU1674673691.USD","BBH","IBBQ","SG9999015952.SGD","IE00B3T34201.USD","LU1430594728.SGD","IE00B19Z3B42.SGD","BIB","MEDI","LU1037948541.HKD","BK4551","LU0114720955.EUR","LU0823416689.USD","BMED","MRNY","BK4566","IDNA","IE00BSNM7G36.USD","LU1585245621.USD","LGHT","GNOM","BK4578","BK4533","BK4548","LU1778281490.HKD","BK4550","BK4532","LU1066053197.SGD","LU0882574055.USD","LU2468319806.SGD","LU1674673428.USD","IBB","LU0109394709.USD","LU0289739699.SGD","LU1023059063.AUD","LU0058720904.USD","MRNX","TMED","SG9999015945.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661323699","title":"Vertex Advances Kidney Disease Pipeline With Completed Inaxaplin Phase 2b Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2661323699","media":"TIPRANKS","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661323699?lang=en_us&edition=fundamental","pubTime":"2026-08-21 00:30","pubTimestamp":1787243431,"startTime":"0","endTime":"0","summary":"Vertex Pharmaceuticals Inc. ($VRTX) announced an update on their ongoing clinical study. The Phase 2b study A Phase 2b, Open-label Study to Evaluat...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-advances-kidney-disease-pipeline-with-completed-inaxaplin-phase-2b-trial?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2362541513.USD","SG9999013999.USD","LU1815336091.USD","SG9999001176.SGD","LU0256863811.USD","IE0009355771.USD","LU1674673428.USD","LU2468319806.SGD","SGXZ57979304.SGD","LU0889565916.HKD","LU0757428866.USD","BIB","BK4588","LU0566484027.USD","LU2237438978.USD","GNMX","SG9999001176.USD","LU1093756168.USD","LU0289739699.SGD","IE00B19Z9P08.USD","IE00B894F039.SGD","LU1093756325.SGD","IE00BFTCPJ56.SGD","IBB","VRTX","PBE","BBH","IBBQ","IE00B2B36J28.USD","LU2089984988.USD","TBXU","LU2417539215.USD","LU2362541273.HKD","IE00B19Z3B42.SGD","LU0079474960.USD","BK4139","LU1069344957.HKD","IE0002141913.USD","LU2324357040.USD","LU2362540622.SGD","BK4567","IDNA","IE00B19Z3581.USD","LU0432979614.USD","VERX","BK4585","LU1674673691.USD","IE00BJJMRZ35.SGD","LU2456880835.USD","LU0234570918.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660728971","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2660728971","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660728971?lang=en_us&edition=fundamental","pubTime":"2026-08-20 19:40","pubTimestamp":1787226007,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Glaukos (GKOS) and Ve...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-306?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4533","LU0823416689.USD","LU2362541513.USD","BIB","IE00BJJMRZ35.SGD","LU0109394709.USD","LU1674673428.USD","LU0256863811.USD","LU2362541273.HKD","LU2462157665.USD","PBE","LU2362540622.SGD","SG9999001176.USD","BK4585","IE00B19Z3B42.SGD","IBBQ","LU1069344957.HKD","BK4588","GKOS","IE00B19Z9P08.USD","IE00B19Z9Z06.USD","LU2417539215.USD","SGXZ57979304.SGD","IE00B894F039.SGD","IE00BJT1NW94.SGD","LU0320765992.SGD","IE0002141913.USD","IE00BZ9MQY76.HKD","GNMX","IE0002270589.USD","VRTX","LU0417517546.SGD","LU1093756325.SGD","LU0079474960.USD","LU1430594728.SGD","SG9999001176.SGD","LU0889565916.HKD","LU2237438978.USD","BK4548","LU0289739699.SGD","LU2324357040.USD","LU1093756168.USD","LU0234570918.USD","LU2089984988.USD","IE0009355771.USD","BK4567","LU0058720904.USD","BK4139","LU1674673691.USD","LU2236285917.USD","IE00B19Z3581.USD","BK4532","LU2468319806.SGD","LU1585245621.USD","BBH","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","LU0061475181.USD","IBB","LU1878469433.USD","IDNA","LU0432979614.USD","IE0009354923.USD","SG9999013999.USD","TBXU","LU1778281490.HKD","LU2456880835.USD","LU1035775433.USD","LU2065731478.USD","BK4082"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660402506","title":"Sino Biopharmaceutical Stock Climbs 13% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660402506","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660402506?lang=en_us&edition=fundamental","pubTime":"2026-08-20 16:31","pubTimestamp":1787214660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. surged 13% to 5.39 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 0.8% to 25698.49.The stock's rise snapped a two-day losing streak.Sino Biopharmaceutical Ltd. closed 41% short of its 52-week high of HK$9.12, which the company achieved Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 9.6% and Amgen Inc. remained unchanged.Trading volume totaled 382.5 million shares, compared to the 50-day average of 95.1 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2089984988.USD","IE0009355771.USD","IBB","BK1515","IE00BZ08YT58.USD","BBH","BK4534","IE00BFTCPJ56.SGD","LU0289739699.SGD","IE00BJJMRZ35.SGD","BK4588","BK1589","LU2112291526.USD","LU2468319806.SGD","LU0889565916.HKD","IE00BJT1NW94.SGD","BIB","IE00B4R5TH58.HKD","LU1057294990.SGD","BK4599","PJP","LU0122379950.USD","SG9999001440.SGD","01177","BK4566","LU0109394709.USD","HK0000165453.HKD","IE0002141913.USD","IE00B2B36J28.USD","IBBQ","LU0058720904.USD","LU1023059063.AUD","LU1061106388.HKD","LU0320765992.SGD","BK4581","BK4585","LU2242652126.USD","BK1191","IE00BZ08YR35.GBP","LU2242646821.SGD","AMGN","BK1521","LU0868494617.USD","IE00BZ08YS42.EUR","TBXU","LU1571399168.USD","PBE","LU1983299246.USD","BK4533","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660479477","title":"Vertex Resource Group Boosts Profitability and Cash Flow in Q2 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2660479477","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660479477?lang=en_us&edition=fundamental","pubTime":"2026-08-20 07:37","pubTimestamp":1787182673,"startTime":"0","endTime":"0","summary":"Vertex Resource Group Ltd. ( ($TSE:VTX) ) has issued an update. Vertex Resource Group Ltd. reported stronger second-quarter 2026 results, highlight...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vertex-resource-group-boosts-profitability-and-cash-flow-in-q2-2026?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0009355771.USD","IE00BJT1NW94.SGD","TBXU","LU0889565916.HKD","SG9999001176.SGD","BBH","IE00B19Z3581.USD","BK4532","LU2237438978.USD","LU1035775433.USD","IBBQ","SG9999013999.USD","LU0320765992.SGD","BK4533","LU0061475181.USD","SGXZ57979304.SGD","LU0234570918.USD","IDNA","IE0002141913.USD","IE00BJJMRZ35.SGD","IE00B19Z9P08.USD","LU2456880835.USD","IBB","BK4585","PBE","LU1778281490.HKD","SG9999001176.USD","LU1815336091.USD","GNMX","LU2236285917.USD","VRTX","LU2089984988.USD","LU0289739699.SGD","BIB","IE00BFTCPJ56.SGD","LU0256863811.USD","IE00B19Z9Z06.USD","IE00B4R5TH58.HKD","LU1093756325.SGD","LU0058720904.USD","LU2468319806.SGD","BK4588","LU1093756168.USD","LU2462157665.USD","BK4023","LU0566484027.USD","LU2362541513.USD","IE0002270589.USD","VERX","IE00BZ9MQY76.HKD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":3,"totalSize":200,"code":"91000000","status":"200"}]}}